Li Mao, MD

Dr. Mao is a worldwide prominent physician-scientist with more than 35 years of extensive experience in clinical practice, clinical and basic research, and leadership in the field of oncology both in China and the U.S..
Prior to joining SciClone, Dr. Mao consecutively held a number of key senior management positions in renowned pharmaceutical companies: he served as the CMO of Sino Biopharmaceutical Co., Ltd. from May 2021 to June 2022, where he was responsible for establishing its R&D center; he led a comprehensive new product launch, overseas merger and acquisitions, and successful NDAs/BLAs in Betta Pharmaceuticals Co., Ltd. from March 2018 to March 2021; and he led the establishment of lung cancer research center at Johnson & Johnson from June 2016 to February 2018.
Before moving into the industry, he served as a tenured Professor and Chairman of Department of Oncology and Diagnostic Sciences at University of Maryland, Baltimore from March 2009 to June 2016. Previously, he served as a tenured Professor in the Department of Thoracic and Head & Neck Medical Oncology and a Professor in the Department of Systems Biology at the University of Texas M.D. Anderson Cancer Center from 2004 to March 2009. Dr. Mao holds a Medical Doctor’s degree from Nanjing Medical University. Dr. Mao also completed a postdoctoral fellowship in cancer genetics at The John Hopkins University School of Medicine.